The Natural Solution For Drug Delivery

DelSiTech™ is an advanced therapeutics delivery technology for implants, subcutaneous and intramuscular administration suitable for the controlled delivery of a wide range of active ingredients, including viruses. The proprietary technology is based on silica (SiO2) matrix into which the active ingredient is embedded. The matrix can be designed to degrade at the required rate to assure a tightly controlled release of the active substance, providing a better therapeutic effect in situ and causing lower systemic toxicological side-effects than alternative delivery systems. The proof of principle has been demonstrated in animal testing both with small synthetic drugs and biologics like viruses.

The technology was developed in two universities by the Biomaterial Research Group in Turku, Finland and is owned and patented by DelSiTech Ltd.